ContraFect Corporation Showcases CF-301 at ICAAC 2014 Meeting in Washington, D.C.

YONKERS, NY — (Marketwired) — 09/02/14 — ContraFect Corporation (NASDAQ: CFRXU), a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious diseases, is pleased to announce that ContraFect has been selected to give an oral presentation at the 54th ICAAC conference (the meeting of the American Society for Microbiology — “ICAAC, the premier conference on antimicrobial agents and infectious diseases, showcases the latest-breaking science and lectures from top researchers around the world” — This year’s ICAAC conference will take placeSeptember 5-9, 2014 at the Walter E. Washington Convention Center in Washington, D.C.

This entry was posted in Recent Development News: Q3 – 2014. Bookmark the permalink.